2008
DOI: 10.1128/jvi.00245-08
|View full text |Cite
|
Sign up to set email alerts
|

Dendritic Cells Preferentially Transfer CXCR4-Using Human Immunodeficiency Virus Type 1 Variants to CD4+T Lymphocytes intrans

Abstract: Human immunodeficiency virus type 1 (HIV-1) preferentially utilizes the CCR5 coreceptor for target cell entry in the acute phase of infection, while later in disease progression the virus switches to the CXCR4 coreceptor in approximately 50% of patients. In response to HIV-1 the adaptive immune response is triggered, and antibody (Ab) production is elicited to block HIV-1 entry. We recently determined that dendritic cells (DCs) can efficiently capture Ab-neutralized HIV-1, restore infectivity, and transmit inf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
30
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
5
1

Relationship

3
3

Authors

Journals

citations
Cited by 26 publications
(31 citation statements)
references
References 57 publications
1
30
0
Order By: Relevance
“…The mechanism for why an MPER bNAb like 2F5 cannot resist DC-mediated HIV-1 transmission was shown for a single R5X4 virus. However, we showed previously that the 2F5 bNAb could not block DC-mediated HIV-1 transmission of viruses using CCR5, CXCR4, or both coreceptors (27). Combined, these results suggest that the MPER Ab-dissociation mechanism is independent of coreceptor usage.…”
Section: Discussionmentioning
confidence: 46%
See 4 more Smart Citations
“…The mechanism for why an MPER bNAb like 2F5 cannot resist DC-mediated HIV-1 transmission was shown for a single R5X4 virus. However, we showed previously that the 2F5 bNAb could not block DC-mediated HIV-1 transmission of viruses using CCR5, CXCR4, or both coreceptors (27). Combined, these results suggest that the MPER Ab-dissociation mechanism is independent of coreceptor usage.…”
Section: Discussionmentioning
confidence: 46%
“…Mature monocyte-derived DCs (mMDDCs) were obtained on day 6 after stimulating iMDDCs on day 5 with 20 mg polyinosinic-polycytidylic acid/ml (Sigma-Aldrich, St. Louis, MO). The phenotypes of both types of DCs were confirmed by flow cytometry (27).…”
Section: Cellsmentioning
confidence: 68%
See 3 more Smart Citations